FM3-Y45

Monoclonal Anti-FMC63 Antibody, Mouse IgG1 (Y45) DMF Filed

FMC63 is an IgG2a mouse monoclonal antibody specific for CD19, which is a target for the immunotherapy of B lineage leukaemias and lymphomas. FMC63 scFv is the most commonly used ectodomain component of CD19-specific CARs. So far, most of reported CART19 trials contain the anti-CD19 scFv derived from FMC63, including the two FDA-approved CARs Kymriah and Yescarta.

9317.76 €

FM3-Y45P1

Monoclonal Anti-FMC63 Antibody, Mouse IgG1 (Y45) (HEK293) DMF Filed

FMC63 is an IgG2a mouse monoclonal antibody specific for CD19, which is a target for the immunotherapy of B lineage leukaemias and lymphomas. FMC63 scFv is the most commonly used ectodomain component of CD19-specific CARs. So far, most of reported CART19 trials contain the anti-CD19 scFv derived from FMC63, including the two FDA-approved CARs Kymriah and Yescarta.

9317.76 €

FM3-Y45P1-1000tests

Monoclonal Anti-FMC63 Antibody, Mouse IgG1 (Y45) (HEK293) DMF Filed

Monoclonal Anti-FMC63 Antibody, Mouse IgG1 (Cat. No. FM3-Y45P1) is expressed from human 293 cells.

9317.76 €

RO1-H5250

Human / Cynomolgus / Rhesus macaque ROR1 Protein, Fc Tag (MALS verified) DMF Filed

Human / Cynomolgus / Rhesus macaque ROR1, Fc Tag (RO1-H5250) is expressed from human 293 cells (HEK293). It contains AA Gln 30 - Glu 403 (Accession # Q01973-1). In the region Gln 30 - Glu 403, the AA sequence of Human, Cynomolgus and Rhesus macaque ROR1 are homologus.

528.00 €

MBS1569772-01mg

Anti-Human CD19 Antibody (FMC63)

663.12 €

MBS1569772-5x01mg

Anti-Human CD19 Antibody (FMC63)

1957.25 €